Endometrial Related Pain
A Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Combined Oral Contraceptives in Premenopausal Women With Documented Endometriosis and Associated Moderate to Severe Pain.
Endometriosis Study in Combination with Oral Contraceptives
Study Length: up to 45 months, which include approximately 14 study visits to the research center and approximately 10 phone calls
Target Age/Sex: 18 to 49 years, Female
Participants will receive at no cost: Study medication and study related procedures. The IRB agreed that for your time and inconvenience related to your participation in this study and to cover the cost of travel, you will be paid for study visits you complete.